| An overview on target-based drug design against kinetoplastid protozoan infections: Human African trypanosomiasis, Chagas disease and leishmaniases V Kourbeli, E Chontzopoulou, K Moschovou, D Pavlos, ... Molecules 26 (15), 4629, 2021 | 75 | 2021 |
| Preparation and biophysical characterization of quercetin inclusion complexes with β-cyclodextrin derivatives to be formulated as possible nose-to-brain quercetin delivery systems K Manta, P Papakyriakopoulou, M Chountoulesi, DA Diamantis, ... Molecular Pharmaceutics 17 (11), 4241-4255, 2020 | 46 | 2020 |
| From angiotensin II to cyclic peptides and angiotensin receptor blockers (ARBs): Perspectives of ARBs in COVID-19 therapy J Matsoukas, V Apostolopoulos, A Zulli, G Moore, K Kelaidonis, ... Molecules 26 (3), 618, 2021 | 18 | 2021 |
| Synthetic analogues of aminoadamantane as influenza viral inhibitors—in vitro, in silico and Qsar Studies R Chayrov, NA Parisis, MV Chatziathanasiadou, E Vrontaki, K Moschovou, ... Molecules 25 (17), 3989, 2020 | 14 | 2020 |
| Cheminformatics and virtual screening studies of COMT inhibitors as potential Parkinson’s disease therapeutics K Moschovou, G Melagraki, T Mavromoustakos, LC Zacharia, A Afantitis Expert Opinion on Drug Discovery 15 (1), 53-62, 2020 | 14 | 2020 |
| Quercetin: a potential polydynamic drug N Georgiou, MG Kakava, EA Routsi, E Petsas, N Stavridis, C Freris, ... Molecules 28 (24), 8141, 2023 | 9 | 2023 |
| Diminazene aceturate reduces angiotensin II constriction and interacts with the spike protein of severe acute respiratory syndrome coronavirus 2 JM Matsoukas, LK Gadanec, A Zulli, V Apostolopoulos, K Kelaidonis, ... Biomedicines 10 (7), 1731, 2022 | 8 | 2022 |
| Exploring the binding effects of natural products and antihypertensive drugs on SARS-CoV-2: an in silico investigation of main protease and spike protein K Moschovou, M Antoniou, E Chontzopoulou, KD Papavasileiou, ... International Journal of Molecular Sciences 24 (21), 15894, 2023 | 3 | 2023 |
| Peptide-based vaccines and altered peptide ligands: Multiple sclerosis paving the way N Zoupanou, N Georgiou, K Moschovou, CT Chasapis, K Kelaidonis, ... Advanced Vaccination Technologies for Infectious and Chronic Diseases, 63-72, 2024 | | 2024 |
| In silico μελέτες βιοδραστικών μορίων που δρουν σε κυτταρικό επίπεδο ή πρωτεϊνικούς υποδοχείς T Mavromoustakos, K Moschovou, D Tzeli, A Kolocouris, E Efthimiadou, ... | | 2023 |
| Computational and NMR studies on LOX inhibition E Chontzopoulou, RA Ioannidi, K Moschovou, P Sket, I Kostakis, ... | | |
